Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Leuk Lymphoma. 2010 Mar;51(3):475-80. doi: 10.3109/10428190903503412. Epub 2010 Jan 18.
The outcome of adults with acute lymphocytic leukemia (ALL) who achieve a complete response (CR) on salvage therapy is thought to be poor, but not previously analyzed. To define the course of adult ALL post CR on salvage therapy and the effects of pretreatment factors on prognosis. One hundred seventy-two adults with ALL who achieved a second or third CR on salvage therapy were reviewed. Prognostic factors affecting survival were analyzed by multivariate analysis. The median survival post achieving CR for the entire group was 10 months. The estimated 1-year survival rate was 42%. Forty-three patients underwent stem cell transplant in subsequent CR: their median survival was 12 months and the 3-year survival rate was 25%. Independent poor prognostic factors for survival were age > 55 years, duration of first CR < 12 months, and lactate dehydrogenase levels > 1000 IU/L. This analysis defines the outcome of adult ALL in CR post salvage therapy and the prognostic factors influencing survival. These results could be used in assessing the efficacy of new treatments aimed at improving CR durations and survival post salvage therapy.
salvage 治疗后达到完全缓解(CR)的成人急性淋巴细胞白血病(ALL)患者的结局被认为较差,但尚未进行分析。为了明确成人 ALL 在 salvage 治疗后获得 CR 后的病程以及预处理因素对预后的影响。对 172 例在 salvage 治疗中获得第二次或第三次 CR 的成人 ALL 患者进行了回顾性分析。采用多因素分析方法分析了影响生存的预后因素。整个研究组获得 CR 后的中位生存时间为 10 个月。估计 1 年的生存率为 42%。43 例患者在随后的 CR 中进行了干细胞移植:他们的中位生存时间为 12 个月,3 年生存率为 25%。生存的独立不良预后因素为年龄>55 岁、首次 CR 持续时间<12 个月和乳酸脱氢酶水平>1000IU/L。本分析明确了成人 ALL 在 salvage 治疗后获得 CR 后的结局以及影响生存的预后因素。这些结果可用于评估旨在延长 CR 持续时间和提高 salvage 治疗后生存的新治疗方法的疗效。